BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33152934)

  • 1. New insights into long non-coding RNAs in non-small cell lung cancer.
    Ye R; Tang R; Gan S; Li R; Cheng Y; Guo L; Zeng C; Sun Y
    Biomed Pharmacother; 2020 Nov; 131():110775. PubMed ID: 33152934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
    Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
    Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer.
    Zhou H; Feng B; Abudoureyimu M; Lai Y; Lin X; Tian C; Huang G; Chu X; Wang R
    Life Sci; 2020 Nov; 261():118362. PubMed ID: 32871184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?
    Osielska MA; Jagodziński PP
    Biomed Pharmacother; 2018 May; 101():322-333. PubMed ID: 29499406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
    Fang C; Wang L; Gong C; Wu W; Yao C; Zhu S
    J Cell Mol Med; 2020 Mar; 24(6):3282-3291. PubMed ID: 32048814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review).
    Tang P; Sun D; Xu W; Li H; Chen L
    Int J Mol Med; 2023 Aug; 52(2):. PubMed ID: 37350412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
    Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance.
    Liu T; Han C; Fang P; Zhu H; Wang S; Ma Z; Zhang Q; Xia W; Wang J; Xu L; Yin R
    Cell Mol Life Sci; 2021 Mar; 78(5):1983-2000. PubMed ID: 33170304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.
    Yu H; Xu Q; Liu F; Ye X; Wang J; Meng X
    J Thorac Oncol; 2015 Apr; 10(4):645-54. PubMed ID: 25590602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of long-chain non-encoding RNA differential expression in non-small cell lung cancer by microarray analysis and preliminary verification.
    Wang Y; Xu G; Chen W; Pan Q; Huang K; Pan J; Zhang W; Chen J
    Mol Med Rep; 2015 Mar; 11(3):1925-32. PubMed ID: 25394782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
    Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
    Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
    Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
    Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.
    Jin M; Ren J; Luo M; You Z; Fang Y; Han Y; Li G; Liu H
    Carcinogenesis; 2020 Jul; 41(5):634-645. PubMed ID: 31253987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance.
    Zheng G; Chen W; Li W; Ding Y; Tu P; Chen W
    Biochem Biophys Res Commun; 2020 Oct; 530(4):624-631. PubMed ID: 32762943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G; Zhu J; Liu F; Yang Y
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
    Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
    Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of long non-coding RNAs and mRNA profiles reveals potential sex-dependent biomarkers of bevacizumab/erlotinib response in advanced lung cancer.
    Tu C; Pi Y; Xing S; Ling Y
    PLoS One; 2020; 15(10):e0240633. PubMed ID: 33075110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary exosomal long noncoding RNAs serve as biomarkers for early detection of non-small cell lung cancer.
    Lin Q; Xie D; Pan L; Lou Y; Shi M
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34580719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.